Ferrous Asparto Glycinate

1
Treating IDA with Ferrous Asparto
Glycinate Iron Deficiency Anaemia in short IDA
is one of the most common nutritional disorders
worldwide. This number is huge and is almost
one-half of anaemia cases. According to the World
Health Organization (WHO), this IDA with
haemoglobin levels lt11 g/dl, is one of the
leading causes of disability (UNU/UNICEF/WHO
2001). There was an investigation in which it was
studied how safe oral Ferrous Asparto Glycinate
and Ferrous Ascorbate in pregnant women suffering
with iron deficiency anaemia (IDA). In this
study, researchers gathered 73 pregnant women at
12 to 26 weeks gestation. The group of women
were divided into two arms. Women in one group
was given Ferrous Ascorbate whereas another group
was treated with Ferrous Asparto Glycinate for a
period of 28 days. On day 14 and 28, the mean
rise in haemoglobin Ferritin levels was
evaluated. The study found that a significant
higher levels of Ferritin and haemoglobin were
found in the group who were treated with Ferrous
Asparto Glycinate as compared to those treated
with Ferrous Ascorbate. So it was concluded that
Ferrous Asparto Glycinate is an effective iron
amino acid chelate in managing IDA in pregnant
women as compared with Ferrous Ascorbate. In
spite of these findings, we need a large scale
clinical trials are required to confirm the
findings. Ferrous Asparto Glycinate is Off white
to light brown color free flowing powder with
occasional friable lumps. If you want to buy
Ferrous Asparto Glycinate in a large quantity,
then contact West Bengal Chemical Industries Ltd.
WBCIL is leading supplier of chemicals in India
and exports to other countries.